Trials / Completed
CompletedNCT05352204
Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas
The Guiding Value of Tumor Micronecrosis for Using Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 900 (actual)
- Sponsor
- Zhejiang University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Micronecrosis is a novel pathological feature of hepatocellular carcinoma (HCC). This study was aimed at evaluating the effect of tumor micronecrosis on postoperative transcatheter arterial chemoembolization (TACE) in patients with hepatocellular carcinomas, and further exploring the value of micronecrosis for guiding TACE in HCC management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | transcatheter arterial chemoembolization | transcatheter arterial chemoembolization after liver resection |
Timeline
- Start date
- 2020-04-30
- Primary completion
- 2022-01-01
- Completion
- 2022-04-14
- First posted
- 2022-04-28
- Last updated
- 2023-02-14
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05352204. Inclusion in this directory is not an endorsement.